278 related articles for article (PubMed ID: 6248217)
1. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
2. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
3. Repeated micro-monocyte adherence inhibition assay: a new technique of leukocyte adherence inhibition to detect tumor immunity in patients with hepatoma.
Kumagai N; Morizane T; Inagaki Y; Nakamura T; Tsuchimoto K; Watanabe T; Tsuchiya M
Gan; 1984 Nov; 75(11):1017-24. PubMed ID: 6097491
[TBL] [Abstract][Full Text] [Related]
4. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
Holán V; Síbl O; Hasek M
Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
[TBL] [Abstract][Full Text] [Related]
7. Leucocyte adherence inhibition assay for immunodiagnosis of hepatocellular carcinoma.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):336-43. PubMed ID: 6092190
[TBL] [Abstract][Full Text] [Related]
8. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
[TBL] [Abstract][Full Text] [Related]
10. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
Lee C; Chen S; Lin T
Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
[TBL] [Abstract][Full Text] [Related]
12. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
Kalafut F; Hung PM; Novotná L; Klobusická M
Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
[TBL] [Abstract][Full Text] [Related]
13. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
Tannenbaum H; Wild J
Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
[TBL] [Abstract][Full Text] [Related]
14. Tube LAI assay in diagnosis and monitoring of a cancer disease.
Hasek M; Holán V; Kousalová M
Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the mechanism of the leukocyte adherence inhibition test.
Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
[TBL] [Abstract][Full Text] [Related]
16. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
17. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
Shenouda G; Thomson DM
Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of leukocyte adherence inhibition (LAI) test in primary and secondary hepatic malignancies.
Tantry BV; Jain AK; Gupta S; Gupta JP
J Surg Oncol; 1984 Nov; 27(3):159-62. PubMed ID: 6092784
[TBL] [Abstract][Full Text] [Related]
19. The leukocyte adherence inhibition assay in rheumatoid arthritis.
Tannenbaum H
J Rheumatol; 1979; 6(6):645-55. PubMed ID: 393822
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]